Japanese drugmaker Takeda Pharmaceutical announced on Thursday that it agreed to acquire Swiss rival Nycomed for roughly $13.7 billion in an effort to expand its presence in Europe and emerging markets.
Magic Circle firm Freshfields Bruckhaus Deringer is advising Nycomed. White & Case is counsel to Stockholm-based Nordic Capital, part of a private equity consortium of selling shareholders cashing out of their investment in the Zurich-based pharmaceutical company.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
